Gustave Roussy Institut to use blockchain for data in cancer drug trials

The Gustave Roussy Institut, a cancer centre in France, is to deploy blockchain in data-sharing applications for oncology research. The technology will be built in partnership with Embleema, a developer of a healthcare blockchain network, and will be used to improve transparency, patient safety and patient engagement in clinical trials.

Global collaboration publishes recommendations to speed rare disease diagnosis

The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.